key: cord-0695578-stun5gt7
authors: Tzedakis, Stylianos; Jeddou, Heithem; Houssel‐Debry, Pauline; Sulpice, Laurent; Boudjema, Karim
title: COVID‐19: Thoughts and comments from a tertiary liver transplant center in France
date: 2020-04-26
journal: Am J Transplant
DOI: 10.1111/ajt.15918
sha: 0146356579eadc53846865b82f42f0916f32df51
doc_id: 695578
cord_uid: stun5gt7

We read with interest the analysis on modern approaches to organ transplantation during the COVID-19 pandemic by Kumar et al.1 . Following the December 2019 SARS-CoV-2 outbreak in China, France is now fifth in number of deaths worldwide while at the same time hosting one of the biggest European liver transplantation programs.

To the Editor:

We read with interest the analysis on modern approaches to organ transplantation during the COVID-19 pandemic by Kumar et al. 1 Following the December 2019 SARS-CoV-2 outbreak in China, France is now fifth in number of deaths worldwide while at the same time hosting one of the biggest European liver transplantation programs.

Past experience with other Coronaviruses outbreaks, such as the SARS-CoV and MERS-CoV, has shown possible transplant recipient contamination and death through their ability to bind to the ACE2 receptors essentially located in the upper and lower respiratory tract but also in liver and bile duct cells. [2] [3] [4] Moreover, liver transplant recipients seem to have more prolonged shedding of virus, owing to immunosuppression, thus potentially increasing the risk of transmission to contacts (super-spreader's effect). 2 Our hospital, located in Rennes, west France (Brittany), hosts the second biggest national liver transplant center. As liver transplant specialists, we think it is crucial to carefully balance costs and benefits in performing a liver transplantation within a COVID-19 epidemic region during a COVID-19 outbreak and decreasing transplant activity might be needed (eg, local center activity has decreased by 60% since the pandemic outbreak). 

The data that support the findings of this study are available from the corresponding author upon reasonable request.

COVID-19: a global transplant perspective on successfully navigating a pandemic

Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening

Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases

https://orcid.org/0000-0002-5934-0320